Potential for longer healthspan: Because GLP-1 drugs can reduce risk factors for chronic diseases (like diabetes, heart disease, and possibly neurodegenerative diseases), they could help people stay healthier for longer as they age
For example, in some countries in Europe high-quality evidence is required, where the more recent treatment is compared to an older pharmacological alternative, but this not the case in all countries (Ford et al., 2009), has caused unavailability for men with IBS-D
Myth: All precursors work the same way
[6:08 PM]source: What Is BPC 157 and Where Does It Come From
That changed on July 1, 2026, when Medicare launched the GLP-1 Bridge Program, which will, for the first time, allow beneficiaries to access GLP-1 medications prescribed specifically for weight loss
All authors contributed in reviewing and editing